Edwards Lifesciences (EW) News Today $73.91 -0.80 (-1.07%) As of 12:44 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 Time Period Edwards Lifesciences Q4 Earnings TranscriptFebruary 21 at 7:21 AM | marketbeat.comEdwards Lifesciences Co. (NYSE:EW) Shares Sold by Handelsbanken Fonder ABHandelsbanken Fonder AB decreased its holdings in Edwards Lifesciences Co. (NYSE:EW - Free Report) by 56.7% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 490,165 shares of the medical research company's stock afFebruary 21 at 4:54 AM | marketbeat.comPrincipal Financial Group Inc. Reduces Position in Edwards Lifesciences Co. (NYSE:EW)Principal Financial Group Inc. cut its position in Edwards Lifesciences Co. (NYSE:EW - Free Report) by 2.9% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 793,925 shares of the medical research company'sFebruary 21 at 3:54 AM | marketbeat.comOwnership Capital B.V. Sells 200,754 Shares of Edwards Lifesciences Co. (NYSE:EW)Ownership Capital B.V. cut its position in shares of Edwards Lifesciences Co. (NYSE:EW - Free Report) by 6.7% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 2,792,265 shares of the medical research company's stock afterFebruary 20 at 5:50 AM | marketbeat.comEdwards Lifesciences Co. (NYSE:EW) Shares Sold by Elk River Wealth Management LLCElk River Wealth Management LLC decreased its holdings in shares of Edwards Lifesciences Co. (NYSE:EW - Free Report) by 92.2% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 5,763 shares of the medical reFebruary 20 at 5:43 AM | marketbeat.comKentucky Retirement Systems Insurance Trust Fund Sells 13,962 Shares of Edwards Lifesciences Co. (NYSE:EW)Kentucky Retirement Systems Insurance Trust Fund reduced its holdings in Edwards Lifesciences Co. (NYSE:EW - Free Report) by 78.3% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 3,874 shares of the medFebruary 20 at 4:36 AM | marketbeat.comCIBC Asset Management Inc Sells 31,973 Shares of Edwards Lifesciences Co. (NYSE:EW)CIBC Asset Management Inc cut its holdings in Edwards Lifesciences Co. (NYSE:EW - Free Report) by 25.5% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 93,427 shares of the medical research company's stock after selling 3February 20 at 4:02 AM | marketbeat.comEmpower Advisory Group LLC Increases Stock Holdings in Edwards Lifesciences Co. (NYSE:EW)Empower Advisory Group LLC grew its holdings in shares of Edwards Lifesciences Co. (NYSE:EW - Free Report) by 9.9% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 775,563 shares of the medical research companyFebruary 18 at 5:26 AM | marketbeat.comEdwards Lifesciences Co. (NYSE:EW) Shares Acquired by Pittenger & Anderson Inc.Pittenger & Anderson Inc. increased its position in shares of Edwards Lifesciences Co. (NYSE:EW - Free Report) by 59.6% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 15,014 shares of the medical research company's stock after acqFebruary 18 at 5:23 AM | marketbeat.comEdwards Lifesciences Corp (EW)'s Winning Formula: Financial Metrics and Competitive StrengthsFebruary 18 at 5:15 AM | gurufocus.comBaillie Gifford & Co. Has $52.32 Million Position in Edwards Lifesciences Co. (NYSE:EW)Baillie Gifford & Co. grew its position in shares of Edwards Lifesciences Co. (NYSE:EW - Free Report) by 238.7% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 706,796 shares of the medical research coFebruary 18 at 4:49 AM | marketbeat.comEdwards Lifesciences' SWOT analysis: stock faces TAVR headwinds, TMTT potentialFebruary 18 at 2:56 AM | msn.comAlphaCentric Advisors LLC Invests $691,000 in Edwards Lifesciences Co. (NYSE:EW)AlphaCentric Advisors LLC bought a new stake in shares of Edwards Lifesciences Co. (NYSE:EW - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 9,333 shares of the medFebruary 17, 2025 | marketbeat.comEdwards Lifesciences Co. (NYSE:EW) Shares Sold by Rhumbline AdvisersRhumbline Advisers trimmed its stake in shares of Edwards Lifesciences Co. (NYSE:EW - Free Report) by 3.3% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,085,905 shares of the medical research companFebruary 17, 2025 | marketbeat.comWD Rutherford LLC Sells 8,893 Shares of Edwards Lifesciences Co. (NYSE:EW)WD Rutherford LLC reduced its holdings in shares of Edwards Lifesciences Co. (NYSE:EW - Free Report) by 48.4% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 9,482 shares of the meFebruary 16, 2025 | marketbeat.comEdwards Lifesciences Co. (NYSE:EW) Shares Sold by New York State Teachers Retirement SystemNew York State Teachers Retirement System trimmed its position in shares of Edwards Lifesciences Co. (NYSE:EW - Free Report) by 8.0% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 482,645 shares of the medical research coFebruary 16, 2025 | marketbeat.comChevy Chase Trust Holdings LLC Sells 13,472 Shares of Edwards Lifesciences Co. (NYSE:EW)Chevy Chase Trust Holdings LLC reduced its stake in Edwards Lifesciences Co. (NYSE:EW - Free Report) by 4.1% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 316,921 shares of the medical research company's stockFebruary 16, 2025 | marketbeat.comVan ECK Associates Corp Has $12.67 Million Holdings in Edwards Lifesciences Co. (NYSE:EW)Van ECK Associates Corp grew its position in shares of Edwards Lifesciences Co. (NYSE:EW - Free Report) by 35.0% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 171,102 shares of the medical research company'sFebruary 16, 2025 | marketbeat.comEdwards Lifesciences Co. (NYSE:EW) Shares Sold by Savant Capital LLCSavant Capital LLC decreased its holdings in Edwards Lifesciences Co. (NYSE:EW - Free Report) by 29.2% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 10,995 shares of the medical research company's stocFebruary 16, 2025 | marketbeat.comInsider Selling: Edwards Lifesciences Co. (NYSE:EW) Director Sells 5,739 Shares of StockEdwards Lifesciences Co. (NYSE:EW - Get Free Report) Director Steven R. Loranger sold 5,739 shares of Edwards Lifesciences stock in a transaction dated Friday, February 14th. The shares were sold at an average price of $76.42, for a total transaction of $438,574.38. Following the transaction, the director now owns 60,372 shares of the company's stock, valued at $4,613,628.24. This represents a 8.68 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink.February 15, 2025 | marketbeat.comWhat is William Blair's Estimate for EW Q1 Earnings?Edwards Lifesciences Co. (NYSE:EW - Free Report) - Equities researchers at William Blair issued their Q1 2026 earnings per share (EPS) estimates for shares of Edwards Lifesciences in a note issued to investors on Wednesday, February 12th. William Blair analyst M. Andrew expects that the medical rFebruary 15, 2025 | marketbeat.comLeerink Partnrs Has Pessimistic Outlook of EW Q1 EarningsEdwards Lifesciences Co. (NYSE:EW - Free Report) - Leerink Partnrs lowered their Q1 2025 earnings estimates for shares of Edwards Lifesciences in a research note issued on Wednesday, February 12th. Leerink Partnrs analyst M. Kratky now anticipates that the medical research company will post earniFebruary 15, 2025 | marketbeat.comEdwards Lifesciences (NYSE:EW) Stock Rating Lowered by Wolfe ResearchWolfe Research downgraded shares of Edwards Lifesciences from a "hold" rating to a "strong sell" rating in a research note on Wednesday.February 15, 2025 | marketbeat.comEdwards Lifesciences Co. (NYSE:EW) Shares Sold by AustralianSuper Pty LtdAustralianSuper Pty Ltd reduced its holdings in Edwards Lifesciences Co. (NYSE:EW - Free Report) by 18.5% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 2,668,843 shares of the medical research company's stock after selling 60February 15, 2025 | marketbeat.comAsset Planning Inc Buys New Shares in Edwards Lifesciences Co. (NYSE:EW)Asset Planning Inc bought a new stake in shares of Edwards Lifesciences Co. (NYSE:EW - Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund bought 26,922 shares of the medical research company's stock, valueFebruary 15, 2025 | marketbeat.comEdwards Lifesciences Co. (NYSE:EW) Holdings Increased by Banque Pictet & Cie SABanque Pictet & Cie SA increased its stake in Edwards Lifesciences Co. (NYSE:EW - Free Report) by 106.2% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 156,968 shares of the medical research compaFebruary 15, 2025 | marketbeat.comBogart Wealth LLC Increases Position in Edwards Lifesciences Co. (NYSE:EW)Bogart Wealth LLC boosted its holdings in Edwards Lifesciences Co. (NYSE:EW - Free Report) by 38.2% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 92,768 shares of the medical research company's stock after purchasing an additional 25,657 shares durFebruary 15, 2025 | marketbeat.comEdwards Lifesciences Co. (NYSE:EW) Director Steven R. Loranger Sells 5,739 SharesFebruary 15, 2025 | insidertrades.comEdwards Lifesciences Co. (NYSE:EW) Shares Sold by First Merchants CorpFirst Merchants Corp lessened its stake in Edwards Lifesciences Co. (NYSE:EW - Free Report) by 85.3% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 10,445 shares of the medical research company'sFebruary 15, 2025 | marketbeat.comEdwards Lifesciences Co. (NYSE:EW) Shares Sold by Vontobel Holding Ltd.Vontobel Holding Ltd. reduced its holdings in Edwards Lifesciences Co. (NYSE:EW - Free Report) by 8.9% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 399,875 shares of the medical research company's stock after selling 3February 15, 2025 | marketbeat.comResearch Analysts Offer Predictions for EW Q1 EarningsFebruary 15, 2025 | americanbankingnews.comLeavell Investment Management Inc. Sells 6,450 Shares of Edwards Lifesciences Co. (NYSE:EW)Leavell Investment Management Inc. decreased its stake in Edwards Lifesciences Co. (NYSE:EW - Free Report) by 65.0% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 3,473 shares of the medical research compaFebruary 15, 2025 | marketbeat.comEdwards Lifesciences (NYSE:EW) Rating Lowered to Strong Sell at Wolfe ResearchFebruary 15, 2025 | americanbankingnews.comEdwards Lifesciences Director Makes a Significant Stock Sale!February 14, 2025 | tipranks.comEdwards Lifesciences Co. (NYSE:EW) VP Donald E. Bobo, Jr. Sells 6,500 SharesEdwards Lifesciences Co. (NYSE:EW - Get Free Report) VP Donald E. Bobo, Jr. sold 6,500 shares of the company's stock in a transaction dated Thursday, February 13th. The stock was sold at an average price of $75.75, for a total value of $492,375.00. Following the completion of the sale, the vice president now owns 46,936 shares in the company, valued at $3,555,402. The trade was a 12.16 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink.February 14, 2025 | marketbeat.comScott B. Ullem Sells 11,250 Shares of Edwards Lifesciences Co. (NYSE:EW) StockEdwards Lifesciences Co. (NYSE:EW - Get Free Report) CFO Scott B. Ullem sold 11,250 shares of the stock in a transaction that occurred on Thursday, February 13th. The shares were sold at an average price of $75.76, for a total value of $852,300.00. Following the transaction, the chief financial officer now directly owns 30,561 shares of the company's stock, valued at $2,315,301.36. The trade was a 26.91 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink.February 14, 2025 | marketbeat.comEdwards Lifesciences Co. (NYSE:EW) VP Donald E. Bobo, Jr. Sells 6,500 SharesFebruary 14, 2025 | insidertrades.comEdwards Lifesciences Co. (NYSE:EW) Shares Sold by Ingalls & Snyder LLCIngalls & Snyder LLC trimmed its holdings in shares of Edwards Lifesciences Co. (NYSE:EW - Free Report) by 34.0% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 6,724 shares of the medical research company'February 14, 2025 | marketbeat.comWhat is Leerink Partnrs' Estimate for EW FY2025 Earnings?February 14, 2025 | americanbankingnews.comDirector Cashes In on Edwards Lifesciences Stock in Major SaleFebruary 13, 2025 | tipranks.comEdwards Lifesciences price target raised to $71 from $66 at CanaccordFebruary 13, 2025 | markets.businessinsider.comEdwards Lifesciences Corporation (NYSE:EW) Q4 2024 Earnings Call TranscriptFebruary 13, 2025 | msn.comBarclays Increases Edwards Lifesciences (NYSE:EW) Price Target to $90.00Barclays lifted their price objective on shares of Edwards Lifesciences from $88.00 to $90.00 and gave the company an "overweight" rating in a research note on Thursday.February 13, 2025 | marketbeat.comLeerink Partnrs Has Negative Outlook of EW FY2025 EarningsEdwards Lifesciences Co. (NYSE:EW - Free Report) - Research analysts at Leerink Partnrs lowered their FY2025 EPS estimates for shares of Edwards Lifesciences in a report released on Wednesday, February 12th. Leerink Partnrs analyst M. Kratky now expects that the medical research company will postFebruary 13, 2025 | marketbeat.comCanaccord Genuity Group Forecasts Strong Price Appreciation for Edwards Lifesciences (NYSE:EW) StockCanaccord Genuity Group increased their price target on Edwards Lifesciences from $68.00 to $71.00 and gave the stock a "hold" rating in a research report on Thursday.February 13, 2025 | marketbeat.comMorgan Stanley Issues Positive Forecast for Edwards Lifesciences (NYSE:EW) Stock PriceMorgan Stanley increased their target price on shares of Edwards Lifesciences from $70.00 to $75.00 and gave the stock an "equal weight" rating in a research report on Wednesday.February 13, 2025 | marketbeat.comCapital Advisors Inc. OK Reduces Position in Edwards Lifesciences Co. (NYSE:EW)Capital Advisors Inc. OK trimmed its holdings in Edwards Lifesciences Co. (NYSE:EW - Free Report) by 45.2% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 5,932 shares of the medical research comFebruary 13, 2025 | marketbeat.comEdwards Lifesciences Stock Outlook: Is Wall Street Bullish or Bearish?February 12, 2025 | msn.comEvercore ISI Reaffirms Their Hold Rating on Edwards Lifesciences (EW)February 12, 2025 | markets.businessinsider.comEdwards Lifesciences (EW) Receives a Buy from Stifel NicolausFebruary 12, 2025 | markets.businessinsider.com Get Edwards Lifesciences News Delivered to You Automatically Sign up to receive the latest news and ratings for EW and its competitors with MarketBeat's FREE daily newsletter. Email Address EW Media Mentions By Week EW Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. EW News Sentiment▼1.100.60▲Average Medical News Sentiment EW News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. EW Articles This Week▼4521▲EW Articles Average Week Get Edwards Lifesciences News Delivered to You Automatically Sign up to receive the latest news and ratings for EW and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Boston Scientific News Stryker News Medtronic News Becton, Dickinson and Company News IDEXX Laboratories News DexCom News ResMed News STERIS News Insulet News Baxter International News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:EW) was last updated on 2/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon “obliterates” Bill Gates?All 10 of the world's biggest money managers follow my work, and the Pentagon, the FBI and Harvard professors ...Altimetry | SponsoredNVDA Crash UpdateAn overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored My 2025 AI BlueprintI first recommended Bitcoin at $300 in 2013 … before it went up 33,645%. Now, I am revealing my 2025 AI Blu...Weiss Ratings | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredBetter than Bitcoin – and potentially more profitableThe world is obsessed with Bitcoin again... And for a good reason: It just soared beyond $100,000. Bitcoin ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Edwards Lifesciences Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Edwards Lifesciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
